About CPF
Company Profiles
Awards
Global Collaboration
Media Center
Subsidiary
Products & Services
API and intermediates
Dosage
Services
R&D
News
Company News
Industry News
Contact Us
中
About CPF
Products & Services
R&D
News
Contact Us
API and intermediates
Dosage
Services
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No.
Product
Crystal form
Current batch size
USDMF
EUDMF
41
Orforglipron
Amorphous
100~300g
42
Osimertinib Mesylate
Form B
10-50g
43
Oteseconazole
Anhydrous crystalline form
2-3Kg
44
Pitavastatin Calcium
45
Pomalidomide
Form A
5.2-10.8kg
DMF
46
Pregabalin
As Innovator
150kg/925kg
USDMF22223
EUDMF/CEP 2016-141
47
Relugolix
Anhydrous Non-solvent Form
17-19kg
DMF
48
Remdesivir
DMF
49
Resmetirom
Form I and Form λ
40-50 kg
50
Rimegepant Sulfate
Form H1.5-1
8-12 kg
USDMF 38655
51
Rivaroxaban
Form Ⅰ
140-150kg
USDMF34436
EUDMF/CEP 2021-252
52
Rosuvastatin Calcium
Amorphous
205kg-225kg
USDMF20705 (RS) /34974 (RSF)
EUDMF /CEP 2015-240(RS) /CEP 2020-430(RSF)
53
Ruxolitinib Phosphate
As Innovator
14-17kg
USDMF
54
Sacubitril Hemicalcium
55
Sacubitril Sodium
Form B
78-80kg
USDMF35962
EUDMF
56
Salcaprozate Sodium(SNAC)
Anhydride (Form I )
50-60 kg
57
SalcaprozateSodium(SNAC)
Anhydride (Form I )
293~328kg
58
Semaglutide
Amorphous
5~10Kg
59
Sofosbuvir
Form Ⅵ
203.9-205.7kg
USDMF32048 (Amorphous)
EUDMF
60
Sugammadex Sodium
Mixed Crystal
17.5-20kg
USDMF37085
EUDMF
1
2
3
4
Leave Your Message
SEND OUT